Werewolf Therapeutics Stock Income Statements

Werewolf Therapeutics Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Werewolf Therapeutics Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30
revenue	1,501,000	5,897,000	8,081,000	4,464,000	7,283,000	4,970,000	4,148,000
cost of revenue	460,000	445,000	773,000	761,000	558,000	708,000	13,887,000
gross profit	1,041,000	5,452,000	7,308,000	3,703,000	6,725,000	4,262,000	-9,739,000
operating expenses
research and development	9,649,000	10,838,000	9,583,000	11,706,000	15,859,000	13,070,000	13,887,000
sales, general and administrative
total operating expenses	14,003,000	15,148,000	14,148,000	16,687,000	20,462,000	17,509,000	19,120,000
operating income	-12,962,000	-9,251,000	-6,067,000	-12,223,000	-13,179,000	-12,539,000	-14,972,000
net income	-12,003,000	-8,285,000	-5,098,000	-11,316,000	-10,681,000	-11,347,000	-14,216,000

We provide you with 20 years income statements for Werewolf Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Werewolf Therapeutics stock. Explore the full financial landscape of Werewolf Therapeutics stock with our expertly curated income statements.

The information provided in this report about Werewolf Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.